Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Current Opinion in Molecular Therapeutics|November 7, 2003
Technology evaluation: R-1549, Antisoma/RochePei Xiang Xing
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 17, 2012
Compact computations based on a stream-function-velocity formulation of two-dimensional steady laminar natural convection in a square cavityPei Xiang Yu, Zhen F Tian
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|May 22, 2013
[Endoscopic ligation in treatment of advanced schistosomiasis patients with esophageal variceal bleeding: a report of 68 cases]Pei-Xiang Liu, Guo-Qing Kong
Current Opinion in Investigational Drugs (London, England : 2000)|December 24, 2005
MDX-060. MedarexXiu Feng Hu, Pei Xiang Xing
Expert Opinion on Therapeutic Targets|June 7, 2005
Cripto as a target for cancer immunotherapyXiu Feng Hu, Pei Xiang Xing
Drug News & Perspectives|September 30, 2005
Cripto monoclonal antibodiesXiu Feng Hu, Pei Xiang Xing
Zhonghua Nan Ke Xue = National Journal of Andrology|December 11, 2012
[Testicular CR16 and spermatogenesis]Xiao-Chun Fu, Wen-Pei Xiang
Current Opinion in Molecular Therapeutics|February 6, 2004
Discovery and validation of new molecular targets for ovarian cancerXiu Feng Hu, Pei Xiang Xing
Cellular Immunology|October 7, 2011
Anti-Pim-1 mAb inhibits activation and proliferation of T lymphocytes and prolongs mouse skin allograft survivalJie Li, Bruce Edward Loveland, Pei Xiang Xing
Pageof 11